Skip to main content
Michael Graber, MD, Pathology, Cincinnati, OH

MichaelWGraberMD

Pathology • Cincinnati, OH

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Graber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Graber's full profile

Already have an account?

  • Office

    2139 Auburn Ave
    Cincinnati, OH 45219
    Phone+1 513-585-2000

Summary

  • Dr. Michael Graber is a pathologist in Syracuse, NY and is affiliated with St. Joseph's Hospital Health Center. He received his medical degree from Albany Medical College and has been in practice 26 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.

Education & Training

  • Albany Medical Center
    Albany Medical CenterFellowship, Hematopathology, 2000 - 2001
  • Albany Medical Center
    Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 2000
  • Albany Medical Center
    Albany Medical CenterInternship, Internal Medicine, 1991 - 1992
  • Albany Medical College
    Albany Medical CollegeClass of 1991

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2023 - 2026
  • NY State Medical License
    NY State Medical License 2001 - 2026
  • IN State Medical License
    IN State Medical License 2023 - 2025
  • KY State Medical License
    KY State Medical License 2023 - 2025
  • OH State Medical License
    OH State Medical License 2023 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Press Mentions

  • Defining a Therapeutic Range for Regeneration of Ischemic Myocardium via Shock Waves
    Defining a Therapeutic Range for Regeneration of Ischemic Myocardium via Shock WavesJanuary 11th, 2021
  • Safety and Efficacy of Direct Cardiac Shockwave Therapy in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting (The CAST-HF Trial): Study Protocol for a Randomized Controlled Trial
    Safety and Efficacy of Direct Cardiac Shockwave Therapy in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting (The CAST-HF Trial): Study Protocol for a Randomized Controlled TrialMay 30th, 2020

Dr. Michael Graber, Dr. Michael Graber, MD, Dr. M Graber, Dr. Michael W Graber